GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Sale Of Property, Plant, Equipment

BCAL Diagnostics (ASX:BDX) Sale Of Property, Plant, Equipment : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Sale Of Property, Plant, Equipment?

BCAL Diagnostics's sale of property, plant, equipment for the six months ended in Dec. 2023 was A$0.00 Mil. It means BCAL Diagnostics gained A$0.00 Mil from selling property, plant, and equipment. BCAL Diagnostics's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

Compared with last quarter (A$0.00 Mil in Jun. 2023 ), BCAL Diagnostics gained the same money from selling property, plant, and equipment in Dec. 2023 (A$0.00 Mil).


BCAL Diagnostics Sale Of Property, Plant, Equipment Historical Data

The historical data trend for BCAL Diagnostics's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Sale Of Property, Plant, Equipment Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23
Sale Of Property, Plant, Equipment
- -

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial - - - - -

BCAL Diagnostics Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BCAL Diagnostics Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


BCAL Diagnostics (ASX:BDX) Business Description

Traded in Other Exchanges
N/A
Address
Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.